• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Accurate Evaluation of Malignant Potential in Pancreatic Ductal Adenocarcinoma Using DUPAN-2 Level.

作者信息

Sumiyoshi Tatsuaki, Uemura Kenichiro

机构信息

Department of Surgeryof Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.

出版信息

Ann Surg Oncol. 2024 Jul;31(7):4697. doi: 10.1245/s10434-024-15272-2. Epub 2024 May 13.

DOI:10.1245/s10434-024-15272-2
PMID:38739237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11164712/
Abstract
摘要

相似文献

1
ASO Author Reflections: Accurate Evaluation of Malignant Potential in Pancreatic Ductal Adenocarcinoma Using DUPAN-2 Level.ASO作者反思：利用DUPAN-2水平准确评估胰腺导管腺癌的恶性潜能
Ann Surg Oncol. 2024 Jul;31(7):4697. doi: 10.1245/s10434-024-15272-2. Epub 2024 May 13.
2
ASO Author Reflections: Prognostic Value of Tumor Deposits in Resected Pancreatic Ductal Adenocarcinoma.ASO作者反思：肿瘤沉积物在切除的胰腺导管腺癌中的预后价值。
Ann Surg Oncol. 2023 May;30(5):3045. doi: 10.1245/s10434-023-13109-y. Epub 2023 Jan 25.
3
ASO Author Reflections: Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma.ASO作者反思：部位重要吗？肿瘤位置对切除的胰腺导管腺癌病理特征、复发及生存的影响
Ann Surg Oncol. 2020 Oct;27(10):3913-3914. doi: 10.1245/s10434-020-08572-w. Epub 2020 May 12.
4
ASO Author Reflections: Prognostic Index after Neoadjuvant Chemotherapy (PINC) in Pancreatic Ductal Adenocarcinoma as Novel Tumor Regression Grading System.ASO作者反思：胰腺导管腺癌新辅助化疗后的预后指数（PINC）作为新型肿瘤消退分级系统
Ann Surg Oncol. 2022 Jun;29(6):3503. doi: 10.1245/s10434-022-11461-z. Epub 2022 Feb 20.
5
ASO Author Reflections: Isolated Margin Positivity in Localized Pancreatic Ductal Adenocarcinoma and Operative Margin Revision.ASO作者反思：局部胰腺导管腺癌的孤立切缘阳性与手术切缘修正
Ann Surg Oncol. 2024 Sep;31(9):6197-6198. doi: 10.1245/s10434-024-15658-2. Epub 2024 Jun 21.
6
ASO Author Reflections: Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail.ASO作者反思：体尾部胰腺导管腺癌中脾脏动脉放射学受累的预后影响
Ann Surg Oncol. 2022 Oct;29(11):7059-7060. doi: 10.1245/s10434-022-11957-8. Epub 2022 Jun 1.
7
ASO Author Reflections: Importance of Preoperative Prediction of Survival in Resectable Pancreatic Ductal Adenocarcinoma.ASO作者反思：可切除性胰腺导管腺癌术前生存预测的重要性
Ann Surg Oncol. 2024 Oct;31(10):7074-7075. doi: 10.1245/s10434-024-15853-1. Epub 2024 Jul 17.
8
ASO Author Reflections: The Need for Improvement of the 8th American Joint Committee on Cancer TNM Staging System for Resected Pancreatic Ductal Adenocarcinoma.美国外科医师学会作者反思：改进第8版美国癌症联合委员会胰腺导管腺癌切除TNM分期系统的必要性。
Ann Surg Oncol. 2022 Sep;29(9):6000-6001. doi: 10.1245/s10434-022-11738-3. Epub 2022 Apr 19.
9
ASO Author Reflections: The Role of Established Prognostic Factors in Long-Term Survival After Resection of Pancreatic Ductal Adenocarcinoma.ASO作者反思：既定预后因素在胰腺导管腺癌切除术后长期生存中的作用
Ann Surg Oncol. 2024 Sep;31(9):6199-6200. doi: 10.1245/s10434-024-15391-w. Epub 2024 May 20.
10
ASO Author Reflections: Postoperative Carbohydrate Antigen 19-9 Levels Become a Reliable Biomarker for Establishing Intensity-Stratified Adjuvant Treatments in Pancreatic Ductal Adenocarcinoma.
Ann Surg Oncol. 2024 Jan;31(1):548-549. doi: 10.1245/s10434-023-14506-z. Epub 2023 Oct 31.

本文引用的文献

1
Prognostic Role of Preoperative Duke Pancreatic Monoclonal Antigen Type 2 Levels in Patients with Pancreatic Cancer.术前杜克胰腺癌单克隆抗原 2 型水平对胰腺癌患者的预后作用。
Ann Surg Oncol. 2023 Sep;30(9):5792-5800. doi: 10.1245/s10434-023-13564-7. Epub 2023 May 29.